Form 4: Pacira BioSciences Executive Sells Shares to Cover Tax Obligations

A Pacira BioSciences executive, Lauren Riker, sold 159 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Lauren Riker, a Senior Vice President at Pacira BioSciences, sold 159 shares of common stock on January 2, 2025.
• The sale was executed at a price of $18.33 per share.
• This transaction was to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Riker directly owns 37,916.335 shares of Pacira BioSciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no significant positive or negative implications for the company's performance or outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the executive, which is typical for these types of transactions.
• Similar transactions can be seen in other biotech and pharmaceutical companies where stock-based compensation is a significant part of executive pay.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive for tax purposes.

Key Dates

Keywords

Pacira BioSciences, stock sale, insider trading, Form 4, executive, tax obligations, restricted stock units